Name: 글로벌 시장 동향
SKU: MI6737
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 경두개 도플러 초음파 시장은 2022년 2,730만 달러 규모에 도달했으며, 2023년부터 2030년까지 연평균 6.7%의 성장률을 보이며 2030년에는 4,300만 달러에 이를 것으로 예상됩니다. 경두개 도플러 초음파 검사는 혈전, 혈관 협착, 지주막하 출혈로 인한 혈관 경련, 미세 혈전 등으로 인한 뇌졸중을 진단하는 데 사용됩니다. 이 검사는 통증이 없으며, 음파를 이용하여 뇌 혈류에 영향을 미치는 질환을 진단합니다.
또한, 이러한 질환의 유병률 증가가 경두개 도플러 초음파 시장 규모 확대를 촉진할 것으로 예상됩니다. 미국과 캐나다 등 의료 서비스 확대로 인해 북미 지역의 수요가 증가하고 있습니다. Viasonix, Rimed, Dawei Medical 등 주요 업체들이 시장에서 활발하게 활동하고 있습니다.

시장 동향
겸형 적혈구 질환 환자 수 증가는 시장 성장을 촉진할 수 있습니다.
겸형 적혈구 질환 환자 수의 증가는 시장 성장을 촉진할 수 있습니다. 예를 들어, 겸형 적혈구 질환(SCD)은 약 10만 명의 미국인에게 영향을 미칩니다. 흑인 또는 아프리카계 미국인 신생아 365명 중 약 1명꼴로, 히스패닉계 미국인 신생아 16,300명 중 약 1명꼴로 SCD가 발생합니다. 흑인 또는 아프리카계 미국인 아기 13명 중 약 1명은 겸형 적혈구 특성(SCT)을 가지고 태어납니다.
또한, 경두개 도플러 초음파는 특정 유형의 겸형 적혈구 질환을 가진 어린이에게 필수적인 검사입니다. 뇌졸중은 겸형 적혈구 질환(SCD)을 앓는 어린이에게 가장 심각한 합병증 중 하나로, 약 5~10%의 어린이에게 영향을 미치며, 발생률은 생후 첫 10년 동안 가장 높습니다. 이 검사는 어린이의 뇌졸중 위험을 판단하는 데 도움이 될 수 있습니다. 따라서 겸형 적혈구 질환 환자 수의 증가는 시장 성장을 촉진할 수 있습니다.

허혈성 뇌졸중 유병률 증가, 시장 성장 가속화 가능성
허혈성 뇌졸중 유병률 증가는 시장 성장을 촉진할 수 있습니다. 예를 들어, 미국에서는 매년 79만 명 이상이 뇌졸중을 겪습니다. 이 중 약 61만 명은 처음 뇌졸중을 경험하는 환자입니다. 약 18만 5천 명(거의 4명 중 1명꼴)은 이전에 뇌졸중을 앓았던 환자에게서 발생합니다. 전체 뇌졸중의 약 87%는 뇌로 가는 혈류가 차단되는 허혈성 뇌졸중입니다.
경두개 도플러(TCD)는 혈전, 혈관 협착, 지주막하 출혈로 인한 혈관 경련, 미세 혈전 등으로 인한 뇌졸중을 감지할 수 있습니다. TCD는 급성 허혈성 뇌졸중 진단에 가장 유용한 도구 중 하나로, 미세 색전, 뇌혈관 협착 정도, 측부 혈류에 대한 귀중한 정보를 제공합니다. 따라서 허혈성 뇌졸중 유병률 증가는 시장 성장을 촉진할 수 있습니다.
하지만 경두개 도플러 초음파(TCD)의 한계점은 시장 성장을 저해할 수 있습니다.
TCD의 한계점으로는 두개골 내 정확한 동맥을 초음파로 탐지하는 데 따르는 기술적 어려움이 있습니다. 또한, 급성 뇌졸중 환자의 12~19%를 차지하는 고령 환자의 경우 두꺼운 두개골로 인해 초음파 에너지가 감쇠되어 도플러 파형을 얻기 어려울 수 있습니다. 프레임 속도가 느릴수록 정보가 평균화되는 경향이 커져 느리게 움직이는 연조직 신호가 플래시 아티팩트로 나타날 수 있습니다. 이처럼 TCD의 한계점은 시장 성장을 저해할 수 있습니다.
세분화 분석
전 세계 경두개 도플러 초음파 시장은 유형, 기술, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
펄스파 도플러(Pulsed Wave Doppler) 부문은 경두개 도플러 초음파 시장 점유율의 약 39.8%를 차지했습니다.
제품의 발전은 이 부문의 성장을 더욱 확대할 수 있습니다. 예를 들어, 2022년 2월 9일, 로열 필립스는 자사의 휴대용 현장 진단 초음파 기기인 루미파이(Lumify)에 향상된 혈류역학 평가 및 측정 기능을 추가하여 초음파 포트폴리오를 확장했다고 발표했습니다. 펄스파 도플러(PW 도플러)는 짧은 초음파 펄스를 보내고 펄스 사이에서 반사된 음파를 분석합니다.
짧고 빠른 음파 펄스를 보내 정확한 위치에서 실시간으로 혈류 속도를 정확하게 측정합니다. 초음파 발생기의 결정체는 초음파를 보내고 분석하는 과정을 빠르게 반복합니다. 이처럼 제품 기술 발전이 지속됨에 따라 해당 부문의 성장이 촉진되고 있습니다.
지역별 시장 점유율
북미는 2022년 시장 점유율의 약 47.2%를 차지했습니다.
북미는 경두개 도플러 초음파 시장에서 중요한 위치를 차지할 것으로 예상됩니다. 기술 발전, 혁신 및 신제품 출시 증가로 인해 이 지역 시장이 성장하고 있습니다. 예를 들어, AI 기반 휴대용 초음파 장비 개발 선두 기업인 에코노우스(EchoNous)는 2021년 3월 4일, 자사의 주력 제품인 코스모스(Kosmos) 하드웨어 플랫폼에 연속파(CW) 및 펄스파(PW) 도플러 기능을 추가했다고 발표했습니다.
이 혁신은 초소형 초음파 제품 업계 최초의 사례로, 휴대용 장비(HCU)에서 광범위한 기기 벤치마킹 초음파 영상 및 도플러 기능을 제공하는 최초의 "하이브리드" 현장 진료 초음파(POCUS) 장비를 탄생시켰습니다. 이처럼 제품의 기술 발전과 신제품 출시가 시장 성장을 견인하고 있습니다.
경쟁 환경
두개골 도플러 초음파 시장의 주요 글로벌 업체로는 비아소닉스(Viasonix), 리메드(Rimed), 다웨이 메디컬(Dawei Medical), 코니카 미놀타 헬스케어 인도(Konica Minolta Healthcare India Pvt.) 등이 있습니다. 주요 기업으로는 NovoSignal Corp, Viasonix, Compumedics Germany GmbH, RIMED, Elekta AB, Shenzhen Delica Medical Equipment Co., Ltd. 등이 있습니다.

COVID-19 영향 분석
COVID-19 팬데믹은 경두개 도플러 초음파 시장에 상당한 영향을 미쳐 많은 국가에 전례 없는 어려움을 초래했습니다. 신제품 출시 및 혁신 지연은 경두개 도플러 초음파 사용량에 부정적인 영향을 미쳤습니다. 제품 승인 건수 감소는 시장 성장을 둔화시켰습니다. 따라서 COVID-19는 경두개 도플러 초음파 시장의 성장을 저해했습니다.

유형별
• 비이중 경두개 초음파(TCD)
• 이중 경두개 초음파(TCD)
기술별
• 연속파 도플러
• 펄스파 도플러
적용 분야별
• 겸상 적혈구 질환
• 급성 허혈성 뇌졸중
• 두개내 협착성 폐쇄 질환
• 혈관 경련
• 기타
최종 사용자별
• 병원
• 진단 연구소
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
주요 개발 사항
• 2023년 2월 28일, NovaSignal은 Jacobs Institute에 NovaGuide 2 지능형 초음파 시스템을 기증한다고 발표했습니다. 미국 버팔로에서 뇌졸중 연구를 발전시키고 실시간 신경 모니터링을 활용하여 해당 지역에서 시술 중 발생하는 심혈관 및 신경혈관 합병증을 감지하고 예방하는 데 도움을 주기 위해 연구를 진행하고 있습니다.
• 2022년 7월 13일, Delica는 미국 FDA의 승인을 받아 경두개 도플러 EMS-9M을 미국 시장에 출시하게 되었음을 발표했습니다. 세계에서 가장 최근에 개발된 무선 경두개 도플러인 EMS-9M은 배터리로 작동하는 시스템입니다. 정지 모드와 활동 모드 모두에서 뇌 평가뿐만 아니라 말초 및 미세혈관 영역 검사에 사용할 수 있습니다.

• 2022년 3월 15일, 뇌 건강 평가 및 관리를 전문으로 하는 의료 기술 및 데이터 회사가 자사의 NovaGuide 지능형 초음파가 캐나다 보건부로부터 의료기기 허가를 받았다고 발표했습니다. 이제 캐나다 의료 종사자들은 NovaGuide를 사용하여 실시간으로 뇌 혈류를 측정하고 모니터링할 수 있습니다.
보고서 구매 이유

• 유형, 기술, 적용 분야, 최종 사용자 및 지역별 글로벌 경두개 도플러 초음파 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 및 공동 개발 분석을 통해 사업 기회를 식별합니다.

• 모든 세그먼트를 포함한 경두개 도플러 초음파 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 Excel 파일로 제공합니다.

글로벌 경두개 도플러 초음파 시장 보고서는 약 53개의 표, 54개의 그림, 195페이지 분량입니다.
주요 대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
The Global Transcranial Doppler Ultrasound Market reachedUS$ 27.3 million in 2022 and is expected to reach US$ 43.0 million by 2030, growing with a CAGR of 6.7% during the forecast period 2023-2030. Transcranial doppler ultrasound test detects stroke caused by blood clots, narrowed sections of blood vessels, vasospasm due to a subarachnoid hemorrhage, and tiny blood clots. It is a painless test that uses sound waves to detect medical problems that affect blood flow in the brain.
Furthermore, the increase in the prevalence of the diseases can elevate the transcranial doppler ultrasound market size. Due to the increase in healthcare expanditure in the countries like the U.S. and Canada, the market is experiencing an increase in demand in North American region. Significant key players like Viasonix, Rimed, Dawei Medical, and others are actively operating in the market.
Market Dynamics
Increase in the Number of Sickle Cell Diseases can Elevate the Market Growth
An increase in the number of sickle cell disorders can elevate the market growth. For instance, sickle cell diseases (SCD) affects approximately 100,000 Americans. SCD occurs among about 1 out of every 365 black or African-American births. SCD occurs among about 1 out of every 16,300 hispanic-American births. About 1 in 13 black or African-American babies is born with sickle cell trait (SCT).
Additionally, transcranial doppler ultrasound is an essential test for children with certain type of sickle cell disease. Stroke is one of the most severe complications in children suffering from sickle cell disease (SCD), affecting approximately 5-10% of children with an incidence peak in the first decade of life. This test can help determine the child's risk for stroke. Thus, an increase in the number of sickle cell diseases can elevate market growth.
Rise in the Prevalence of Ischemic Strokes can Accelerate Market Growth
The increase in the prevalence of ischemic strokes can elevate market growth. For instance, every year, more than 790,000 people in the United States have a stroke. About 610,000 of these are first or new strokes. About 185,000 strokes—nearly 1 in 4—are in people with a previous stroke. About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked.
It can detect stroke caused by blood clots, narrowed sections of blood vessels, vasospasm due to a subarachnoid hemorrhage, tiny blood clots, and more. Transcranial doppler (TCD) is one of the most useful tools in diagnosing acute ischemic stroke. It provides valuable information about microemboli, the degree of cerebral vessel stenosis, and collateral flow. Thus, an increase in the prevalence of ischemic strokes can raise market growth.
Limitations associated with the TCDs can HamperMarket Growth
The limitations associated with the TCDs are technical challenges to insonate the correct artery within the cranial vault. It may also be difficult to obtain doppler waveforms in elderly patients because of the attenuation of ultrasound energy through a thick skull typical in such patients (12–19% of patients with acute stroke). Because of more averaging of information at slower frame rates, slow-moving soft tissue signals appear as flash artifacts. Thus, the limitations associated with TCDs can hamper market growth.
Segment Analysis
The global transcranial doppler ultrasound market is segmented based on type, technology, application, end-user and region.
The Pulsed Wave Doppler Segment Accounted for Approximately 39.8% of the Transcranial Doppler Ultrasound Market Share.
The increase in the advancements of the products can expand the growth of the segment. For instance, on February 9, 2022, Royal Philips announced it has expanded its ultrasound portfolio with advanced hemodynamic assessment and measurement capabilities on the company’s Lumify handheld point-of-care ultrasound device. The pulsed wave doppler (PW Doppler) sends short pulses of ultrasound and analyzes reflected sound waves between the pulses.
By sending short and quick pulses of sound, it accurately measures the velocity of blood in a precise location and in real time. The crystals alternate rapidly between sending and analyzing ultrasound. Thus, an increase in the advancements in the products is driving the growth of the segment.
Geographical Penetration
North America Accounted for Approximately 47.2% of the Market Share in 2022.
North America is expected to hold a significant position in the transcranial doppler ultrasound market share. Due to the increase in technological advancements, innovations, and launches, there is a growth of the market in this region. For instance, on March 4, 2021, EchoNous, the leading developer of AI-driven, hand-carried ultrasound, announced the addition of both continuous wave (CW) and pulsed wave (PW) doppler capabilities to the Kosmos hardware platform, the company's flagship offering.
This innovation represents an industry first for an ultra-mobile ultrasound product, creating the first "hybrid" point-of-care ultrasound (POCUS) device, offering extensive machine-benchmarked ultrasound imaging and doppler functionality in a hand-carried unit (HCU). Thus, an increase in technological advancements in the products and the launches is driving the growth of the market.
Competitive Landscape
The major global players in the transcranial doppler ultrasound market include Viasonix, Rimed, Dawei Medical, Konica Minolta Healthcare India Pvt. Ltd., NovoSignal Corp, Viasonix, Compumedics Germany GmbH, RIMED, Elekta AB, Shenzhen Delica Medical Equipment Co., Ltd. and among others.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant influence on the transcranial doppler ultrasound market, posing unprecedented challenges to many countries. The delayed launches and innovations have shown a negative impact on the usage of transcranial doppler ultrasound. The reduced number of product approvals has reduced market growth. Thus, COVID-19 has declined the growth of the transcranial doppler ultrasound market.
By Type
• Non-Duplex TCDs
• Duplex TCDs
By Technology
• Continuous wave Doppler
• Pulsed Wave Doppler
By Application
• Sickle Cell Disease
• Acute Ischemic Stroke
• Intracranial Steno Occlusive Disease
• Vasospasm
• Others
By End-User
• Hospitals
• Diagnostic Laboratories
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
• On February 28, 2023, NovaSignal announced the donation of a NovaGuide 2 intelligent ultrasound system to the Jacobs Institute in Buffalo, USA, in order to advance stroke research and use real-time neuromonitoring to detect and help prevent intraprocedural cardiovascular and neurovascular complications in the region.
• On July 13, 2022, Delica is pleased to announce that they have begun serving the US market with the approval of the Transcranial Doppler EMS-9M by the US FDA. Most recent wireless TCD in the world is called EMS-9M. It is a battery-powered, battery-powered system. Both in sedentary and active modes, it can be used for cerebral evaluations as well as investigations of peripheral and microvascular regions.
• On March 15, 2022, a medical technology and data company specializing in the assessment and management of brain health announced that its NovaGuide Intelligent Ultrasound has been granted a Medical Device Licence by Health Canada. NovaGuide is now available to Canadian healthcare practitioners for use in capturing and monitoring blood flow in the brain in real-time.
Why Purchase the Report?
• To visualize the global transcranial doppler ultrasound market segmentation based on type, technology, application, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of transcranial doppler ultrasound market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available in Excel consisting of key products of all the major players.
The global transcranial doppler ultrasound market report would provide approximately 53 tables, 54 figures, and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End-user
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increase in the Number of Sickle Cell Diseases
4.1.1.2. Rise in the Prevalence of Ischemic Strokes
4.1.2. Restraints
4.1.2.1. Limitations Associated with the TCDs
4.1.3. Opportunity
4.1.3.1. Advancements in the Diagnostic Devices
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Non-Duplex TCDs
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Duplex TCDs
8. By Technology
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.1.2. Market Attractiveness Index, By Technology
8.2. Continuous wave Doppler
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Pulsed Wave Doppler
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Sickle Cell Disease
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Acute Ischemic Stroke
9.4. Intracranial Steno Occlusive Disease
9.5. Vasospasm
9.6. Others
10. By End-user
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.1.2. Market Attractiveness Index, By End-user
10.2. Hospitals
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Laboratories
10.4. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Spain
11.3.7.5. Italy
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Viasonix
13.1.1. Company Overview
13.1.2. ProductPortfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Rimed
13.3. Dawei Medical
13.4. Konica Minolta Healthcare India Pvt. Ltd.
13.5. NovoSignal Corp
13.6. Viasonix
13.7. Compumedics Germany GmbH
13.8. RIMED
13.9. Elekta AB,
13.10. Shenzhen Delica Medical Equipment Co., Ltd.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Viasonix, 4.	Key Developments, Rimed, Dawei Medical, Konica Minolta Healthcare India Pvt. Ltd., NovoSignal Corp, Viasonix, Compumedics Germany GmbH, RIMED, Elekta AB,, Shenzhen Delica Medical Equipment Co., Ltd.

표 목록 (Tables)

List of Tables

Table 1 Global Transcranial Doppler Ultrasound Market Value, By Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Transcranial Doppler Ultrasound Market Value, By Technology, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Transcranial Doppler Ultrasound Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Transcranial Doppler Ultrasound Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Transcranial Doppler Ultrasound Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Transcranial Doppler Ultrasound Market Value, By Type, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Transcranial Doppler Ultrasound Market Value, By Type, 2021-2030 (US$ Million)

Table 8 Global Transcranial Doppler Ultrasound Market Value, By Technology, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Transcranial Doppler Ultrasound Market Value, By Technology, 2021-2030 (US$ Million)

Table 10 Global Transcranial Doppler Ultrasound Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Transcranial Doppler Ultrasound Market Value, By Application, 2021-2030 (US$ Million)

Table 12 Global Transcranial Doppler Ultrasound Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Transcranial Doppler Ultrasound Market Value, By End-User, 2021-2030 (US$ Million)

Table 14 Global Transcranial Doppler Ultrasound Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Transcranial Doppler Ultrasound Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Transcranial Doppler Ultrasound Market Value, By Type, 2021-2030 (US$ Million)

Table 17 North America Transcranial Doppler Ultrasound Market Value, By Technology, 2021-2030 (US$ Million)

Table 18 North America Transcranial Doppler Ultrasound Market Value, By Application, 2021-2030 (US$ Million)

Table 19 North America Transcranial Doppler Ultrasound Market Value, By End-User, 2021-2030 (US$ Million)

Table 20 North America Transcranial Doppler Ultrasound Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Transcranial Doppler Ultrasound Market Value, By Type, 2021-2030 (US$ Million)

Table 22 South America Transcranial Doppler Ultrasound Market Value, By Technology, 2021-2030 (US$ Million)

Table 23 South America Transcranial Doppler Ultrasound Market Value, By Application, 2021-2030 (US$ Million)

Table 24 South America Transcranial Doppler Ultrasound Market Value, By End-User, 2021-2030 (US$ Million)

Table 25 South America Transcranial Doppler Ultrasound Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Transcranial Doppler Ultrasound Market Value, By Type, 2021-2030 (US$ Million)

Table 27 Europe Transcranial Doppler Ultrasound Market Value, By Technology, 2021-2030 (US$ Million)

Table 28 Europe Transcranial Doppler Ultrasound Market Value, By Application, 2021-2030 (US$ Million)

Table 29 Europe Transcranial Doppler Ultrasound Market Value, By End-User, 2021-2030 (US$ Million)

Table 30 Europe Transcranial Doppler Ultrasound Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Transcranial Doppler Ultrasound Market Value, By Type, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Transcranial Doppler Ultrasound Market Value, By Technology, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Transcranial Doppler Ultrasound Market Value, By Application, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Transcranial Doppler Ultrasound Market Value, By End-User, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Transcranial Doppler Ultrasound Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Transcranial Doppler Ultrasound Market Value, By Type, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Transcranial Doppler Ultrasound Market Value, By Technology, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Transcranial Doppler Ultrasound Market Value, By Application, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Transcranial Doppler Ultrasound Market Value, By End-User, 2021-2030 (US$ Million)

Table 40 Viasonix: Overview

Table 41 Viasonix: Product Portfolio

Table 42 Viasonix: Key Developments

Table 43 Rimed: Overview

Table 44 Rimed: Product Portfolio

Table 45 Rimed: Key Developments

Table 46 Dawei Medical: Overview

Table 47 Dawei Medical: Product Portfolio

Table 48 Dawei Medical: Key Developments

Table 49 Konica Minolta Healthcare India Pvt. Ltd.: Overview

Table 50 Konica Minolta Healthcare India Pvt. Ltd.: Product Portfolio

Table 51 Konica Minolta Healthcare India Pvt. Ltd.: Key Developments

Table 52 NovoSignal Corp: Overview

Table 53 NovoSignal Corp: Product Portfolio

Table 54 NovoSignal Corp: Key Developments

Table 55 Viasonix: Overview

Table 56 Viasonix: Product Portfolio

Table 57 Viasonix: Key Developments

Table 58 Compumedics Germany GmbH: Overview

Table 59 Compumedics Germany GmbH: Product Portfolio

Table 60 Compumedics Germany GmbH: Key Developments

Table 61 RIMED: Overview

Table 62 RIMED: Product Portfolio

Table 63 RIMED: Key Developments

Table 64 Elekta AB: Overview

Table 65 Elekta AB: Product Portfolio

Table 66 Elekta AB: Key Developments

Table 67 Shenzhen Delica Medical Equipment Co., Ltd.: Overview

Table 68 Shenzhen Delica Medical Equipment Co., Ltd.: Product Portfolio

Table 69 Shenzhen Delica Medical Equipment Co., Ltd.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 2 Global Transcranial Doppler Ultrasound Market Share, By Type, 2022 & 2030 (%)

Figure 3 Global Transcranial Doppler Ultrasound Market Share, By Technology, 2022 & 2030 (%)

Figure 4 Global Transcranial Doppler Ultrasound Market Share, By Application, 2022 & 2030 (%)

Figure 5 Global Transcranial Doppler Ultrasound Market Share, By End-User, 2022 & 2030 (%)

Figure 6 Global Transcranial Doppler Ultrasound Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Transcranial Doppler Ultrasound Market Y-o-Y Growth, By Type, 2022-2030 (%)

Figure 8 Non-Duplex TCDs Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 9 Duplex TCDs Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 10 Global Transcranial Doppler Ultrasound Market Y-o-Y Growth, By Technology, 2022-2030 (%)

Figure 11 Continuous wave Doppler Technology in Global Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 12 Pulsed Wave Doppler Technology in Global Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 13 Global Transcranial Doppler Ultrasound Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 14 Sickle Cell Disease Application in Global Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 15 Acute Ischemic Stroke Application in Global Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 16 Intracranial Steno Occlusive Disease Application in Global Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 17 Vasospasm Application in Global Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 18 Global Transcranial Doppler Ultrasound Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 19 Hospitals End-User in Global Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 20 Diagnostic Laboratories End-User in Global Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 21 Others End-User in Global Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 22 Global Transcranial Doppler Ultrasound Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 23 North America Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 24 Asia-Pacific Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 25 Europe Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 26 South America Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 27 Middle East and Africa Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 28 North America Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 29 North America Transcranial Doppler Ultrasound Market Share, By Type, 2022 & 2030 (%)

Figure 30 North America Transcranial Doppler Ultrasound Market Share, By Technology, 2022 & 2030 (%)

Figure 31 North America Transcranial Doppler Ultrasound Market Share, By Application, 2022 & 2030 (%)

Figure 32 North America Transcranial Doppler Ultrasound Market Share, By End-User, 2022 & 2030 (%)

Figure 33 North America Transcranial Doppler Ultrasound Market Share, By Country, 2022 & 2030 (%)

Figure 34 South America Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 35 South America Transcranial Doppler Ultrasound Market Share, By Type, 2022 & 2030 (%)

Figure 36 South America Transcranial Doppler Ultrasound Market Share, By Technology, 2022 & 2030 (%)

Figure 37 South America Transcranial Doppler Ultrasound Market Share, By Application, 2022 & 2030 (%)

Figure 38 South America Transcranial Doppler Ultrasound Market Share, By End-User, 2022 & 2030 (%)

Figure 39 South America Transcranial Doppler Ultrasound Market Share, By Country, 2022 & 2030 (%)

Figure 40 Europe Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 41 Europe Transcranial Doppler Ultrasound Market Share, By Type, 2022 & 2030 (%)

Figure 42 Europe Transcranial Doppler Ultrasound Market Share, By Technology, 2022 & 2030 (%)

Figure 43 Europe Transcranial Doppler Ultrasound Market Share, By Application, 2022 & 2030 (%)

Figure 44 Europe Transcranial Doppler Ultrasound Market Share, By End-User, 2022 & 2030 (%)

Figure 45 Europe Transcranial Doppler Ultrasound Market Share, By Country, 2022 & 2030 (%)

Figure 46 Asia-Pacific Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 47 Asia-Pacific Transcranial Doppler Ultrasound Market Share, By Type, 2022 & 2030 (%)

Figure 48 Asia-Pacific Transcranial Doppler Ultrasound Market Share, By Technology, 2022 & 2030 (%)

Figure 49 Asia-Pacific Transcranial Doppler Ultrasound Market Share, By Application, 2022 & 2030 (%)

Figure 50 Asia-Pacific Transcranial Doppler Ultrasound Market Share, By End-User, 2022 & 2030 (%)

Figure 51 Asia-Pacific Transcranial Doppler Ultrasound Market Share, By Country, 2022 & 2030 (%)

Figure 52 Middle East & Africa Transcranial Doppler Ultrasound Market Value, 2021-2030 (US$ Million)

Figure 53 Middle East & Africa Transcranial Doppler Ultrasound Market Share, By Type, 2022 & 2030 (%)

Figure 54 Middle East & Africa Transcranial Doppler Ultrasound Market Share, By Technology, 2022 & 2030 (%)

Figure 55 Middle East & Africa Transcranial Doppler Ultrasound Market Share, By Application, 2022 & 2030 (%)

Figure 56 Middle East & Africa Transcranial Doppler Ultrasound Market Share, By End-User, 2022 & 2030 (%)

Figure 57 Viasonix: Financials

Figure 58 Rimed: Financials

Figure 59 Dawei Medical: Financials

Figure 60 Konica Minolta Healthcare India Pvt. Ltd.: Financials

Figure 61 NovoSignal Corp: Financials

Figure 62 Viasonix: Financials

Figure 63 Compumedics Germany GmbH: Financials

Figure 64 RIMED: Financials

Figure 65 Elekta AB: Financials

Figure 66 Shenzhen Delica Medical Equipment Co., Ltd.: Financials

글로벌 경두개 도플러 초음파 시장 – 2023-2030

Global Transcranial Doppler Ultrasound Market - 2023-2030